Health Sciences Research Awards and Grants
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Mechanisms by Which Human Milk-Derived OligosaccharidesProtect Intestinal Barrier and Attenuate Inflammation | Grant | 107,210.00 | Research | Pawel Kiela | Pediatrics | Vanderbilt University Medical Center | 02/2025 |
| Microbiome and Nutrition in Severe PARDS | Grant | 142,299.00 | Research | Pawel Kiela | Pediatrics | Baylor College of Medicine | 02/2025 |
| Molecular Approach for Oropharyngeal Cancer Detection in Non-Plasma Biofluid | Grant | 99,863.50 | Research | Mark Nelson | Pathology and Lab Medicine | Flinn Foundation | 02/2025 |
| New Date. The First Accurate Due Date Predictor | Grant | 100,000.00 | Research | Elise Erickson | College of Nursing | Flinn Foundation | 02/2025 |
| Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis | Grant | 150,000.00 | Research | Michael Fallon | COM Phx Internal Medicine | FAKnostics, LLC | 02/2025 |
| Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer's Disease Risk | Grant | 58,820.00 | Research | Michael Grandner | Psychiatry | University of Utah | 02/2025 |
| Plant Exosomes (PEVs) for Cell and Gene Therapies | Contract | 97,898.00 | Research | Frederic Zenhausern | COM Phx NanoBioscience & Med | HonorHealth | 02/2025 |
| Predictive Diagnostics for Immunomodulatory Therapy in Inflammatory and Fibrotic Disease | Grant | 100,000.00 | Research | Steven Goldman | Sarver Heart Center | Flinn Foundation | 02/2025 |
| Puentes de Salud: Bridging Mental Health Gaps for Santa Cruz Seniors | Contract | 100,000.00 | Other Sponsored Activity | Sheila Soto | Public Hlth Prac & Trans Rsch | Santa Cruz County, Arizona | 02/2025 |
| Ravulizumab To Protect Patients with Chronic Kidney Disease (CKD) From Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized | Contract | * | Clinical Trial | Toshinobu Kazui | Surgery | Alexion Pharmaceuticals, Incorporated | 02/2025 |
| Regenerating the Parkinson's Brain: Assessing the Effect of Allopregnanolone on Striatal Dopamine Transporters | Grant | 100,000.00 | Research | Roberta Brinton | UAHS Brain Science | Flinn Foundation | 02/2025 |
| State Opioid Response (SOR IV) | Grant | 3,017,621.00 | Research | Maria Manriquez-Sanchez | COM Phx Obstetrics&Gynecology | Arizona Health Care Cost Containment System | 02/2025 |
| Targeting Drug Resistance in the Bone Microenvironment Using a Novel PIM-PROTAC | Grant | 1,791,407.00 | Research | Noel Warfel | Cellular & Molecular Medicine | United States Army Medical Research Acquisition Activity | 02/2025 |
| Targeting the Genotype to Phenotype Link in HCM as a Therapeutic Strategy | Grant | 472,457.00 | Research | Nipavan Chiamvimonvat | COM Phx Basic Medical Sci | Stanford University | 02/2025 |
| Training in Cardiovascular Drug Discovery | Grant | 165,000.00 | Research Training | Jared Churko | Cellular & Molecular Medicine | American Heart Association, Incorporated | 02/2025 |
| Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation ? Redo Ablation Procedures: A Pilot Study | Contract | * | Clinical Trial | Roderick Tung | COM Phx Internal Medicine | Icahn School of Medicine at Mount Sinai | 02/2025 |
| WHO Expert Committee on Drug Dependence: Critical Review of Coca Leaf | 65,339.00 | Stephen Dahmer | Andrew Weil Ctr Intgrtv Med | World Health Organization (Switzerland) | 02/2025 | ||
| Wildcat Nurse Wellness: Exploring the Parallels between Student and Faculty Wellness | Grant | 2,000.00 | Research | Cheryl Lacasse | College of Nursing | Sigma Theta Tau International | 02/2025 |
| A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (GLORA S | Contract | * | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Ascentage Pharma | 01/2025 |
| A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy | Contract | * | Clinical Trial | David Labiner | Neurology | Worldwide Clinical Trials | 01/2025 |
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.